Exploring tumor environments using advanced imaging techniques
IMAT-ITCR Collaboration: Combining FIBI and topological data analysis: Synergistic approaches for tumor structural microenvironment exploration
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA AT DAVIS · NIH-10885376
This study is looking at how different imaging techniques can help us better understand the environment around breast cancer tumors, with the goal of improving diagnosis and treatment for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA AT DAVIS (nih funded) |
| Locations | 1 site (DAVIS, UNITED STATES) |
| Trial ID | NIH-10885376 on ClinicalTrials.gov |
What this research studies
This research investigates the structural microenvironment of tumors, specifically focusing on breast cancer, by comparing two imaging techniques: Fluorescence Imitating Brightfield Imaging (FIBI) and traditional hematoxylin and eosin (H&E) staining. The study aims to utilize novel mathematical tools to quantify the differences and similarities in the images produced by these methods. By enhancing the understanding of tumor microenvironments, the research seeks to improve diagnostic capabilities and clinical outcomes for patients. The approach involves collaboration between experts at Stony Brook University and UC Davis to validate the effectiveness of FIBI as a diagnostic tool.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with breast cancer who are undergoing imaging for diagnostic purposes.
Not a fit: Patients with non-malignant conditions or those not undergoing imaging for breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic imaging techniques for breast cancer, enhancing early detection and treatment strategies.
How similar studies have performed: Previous studies have shown promising results with FIBI, indicating its potential as a diagnostic tool, although this specific approach is relatively novel.
Where this research is happening
DAVIS, UNITED STATES
- UNIVERSITY OF CALIFORNIA AT DAVIS — DAVIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEVENSON, RICHARD M. — UNIVERSITY OF CALIFORNIA AT DAVIS
- Study coordinator: LEVENSON, RICHARD M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Cancers, neoplasm/cancer